SCHEMBL4457861

SCHEMBL4457861

O=C(O)Nc1cccc(-n2cncn2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.47
BRD4 O60885 1/20 0.47
CREBBP Q92793 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.44
CYP2A6 P11509 1/20 0.44
GRK6 P43250 1/20 0.44
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
ALDH1A1 P00352 3/20 0.42
ADORA3 P0DMS8 1/20 0.42
ADORA2A P29274 1/20 0.42
ADORA1 P30542 1/20 0.42
POLB P06746 2/20 0.42
RAB9A P51151 3/20 0.41
KDM4E B2RXH2 2/20 0.41
NPC1 O15118 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
IDE P14735 1/20 0.41
MAPK1 P28482 2/20 0.40
HCRTR1 O43613 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5328745 0.82 GRK6 (0.47) S1PR1BRD4CREBBPSMN1; SMN2CYP2A6
SCHEMBL1165268 0.81 SMN1; SMN2 (0.53) S1PR1BRD4CREBBPSMN1; SMN2CYP2A6
SCHEMBL18974765 0.81 KMT2A (0.47) S1PR1BRD4CREBBPSMN1; SMN2CYP2A6
SCHEMBL1020544 0.78 CYP2A6 (0.49) S1PR1BRD4CREBBPSMN1; SMN2CYP2A6
SCHEMBL940731 0.77 MAOA (0.49) SMN1; SMN2CYP2A6GRK6MEN1KMT2A
SCHEMBL11926858 0.77 CYP2A6 (0.62) BRD4CREBBPSMN1; SMN2CYP2A6GRK6
SCHEMBL4456344 0.75 ACLY (0.46) SMN1; SMN2MEN1KMT2AALDH1A1POLB
SCHEMBL6756584 0.75 MAPT (0.60) SMN1; SMN2MEN1KMT2AALDH1A1POLB
SCHEMBL6756583 0.75 MAPT (0.60) SMN1; SMN2MEN1KMT2AALDH1A1POLB
SCHEMBL5252164 0.75 HDAC1 (0.45) S1PR1BRD4CREBBPSMN1; SMN2CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009090548-A2 3-AZABICYCLO [3.1.0] HEXANE DERIVATIVES AS VANILLOID RECEPTOR LIGANDS GLENMARK PHARMACEUTICALS, S.A. (US) 2009-07-23 WO disclosed